Lacer, S.A. (Lacer) is a research focused biotechnology company. It is principally engaged in the development and commercialization of innovative prescription based products and over-the-counter products. It operates through its three main divisions namely, pharmaceutical, personal health and industrial division. The company offers a broad portfolio of prescription and over-the-counter therapeutic products for the areas of cardiovascular diseases, peripheral vascular disorders, gastrointestinal, musculoskeletal, central nervous system, oral health, hair and scalp, dermatology, body and skin care and protection and allergy. Lacer also offers its MAPAPRES network to primary-care doctors and hypertension specialists for analysis of the circadian profile of patients with high blood pressure. Recently, the company acquires the product Talquistina. The company is headquartered in Barcelona, Spain.